Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1340 (LINC01340) is a long non-coding RNA gene in humans, located outside of annotated protein-coding regions[1][3][5]. As a member of the lincRNA family, it is transcribed into a noncoding RNA molecule longer than 200 nucleotides and does not overlap protein-coding genes. The function of LINC01340 has not been clearly characterized; more broadly, lincRNAs have diverse regulatory roles in chromatin architecture, gene expression control, and RNA metabolism, but only a small fraction have been functionally annotated[3][5]. LINC01340 has no validated role in disease, no known interacting drugs, nor any documented safety concerns. It should be classified as a lincRNA with currently unknown relevance to human disease or pharmacology. If more specific structural, pathway, or cellular role information becomes available in curated databases or primary research, "disease_roles," "biological_functions," or "molecular_classifications" may be refined, but as of now, LINC01340 is best described as a human lincRNA with unknown or unconfirmed biological and clinical significance[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1340 (LINC01340).